Legal & General Group
ALT icon

Legal & General Group’s Altimmune ALT Stock Holding History

Legal & General Group’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$35.4K Buy
11,496
+2,134
+23% +$9.06K ﹤0.01% 2770
2025
Q4 		$33.8K Buy
9,362
+742
+9% +$3.23K ﹤0.01% 2833
2025
Q3 		$32.5K Hold
8,620
– – ﹤0.01% 2852
2025
Q2 		$33.3K Sell
8,620
-59,482
-87% -$322K ﹤0.01% 2813
2025
Q1 		$340K Hold
68,102
– – ﹤0.01% 2515
2024
Q4 		$491K Sell
68,102
-500
-0.7% -$3.82K ﹤0.01% 2462
2024
Q3 		$421K Buy
68,602
+6,424
+10% +$43.5K ﹤0.01% 2521
2024
Q2 		$413K Buy
62,178
+16,563
+36% +$122K ﹤0.01% 2478
2024
Q1 		$464K Buy
45,615
+41,230
+940% +$419K ﹤0.01% 2460
2023
Q4 		$49.3K Sell
4,385
-337
-7% -$1.41K ﹤0.01% 2808
2023
Q3 		$12.3K Hold
4,722
– – ﹤0.01% 3225
2023
Q2 		$16.7K Buy
4,722
+2,181
+86% +$9.79K ﹤0.01% 3185
2023
Q1 		$10.7K Sell
2,541
-10,504
-81% -$125K ﹤0.01% 3197
2022
Q4 		$215K Sell
13,045
-40,502
-76% -$455K ﹤0.01% 2583
2022
Q3 		$684K Buy
+53,547
New +$791K ﹤0.01% 2260
2022
Q2 		– Sell
-3,166
Closed -$19K – 3522
2022
Q1 		$19K Hold
3,166
– – ﹤0.01% 3253
2021
Q4 		$29K Hold
3,166
– – ﹤0.01% 3157
2021
Q3 		$36K Buy
3,166
+572
+22% +$6.96K ﹤0.01% 3067
2021
Q2 		$26K Buy
+2,594
New +$35.5K ﹤0.01% 3187
2017
Q3 		– Sell
-6
Closed -$1K – 3306
2017
Q2 		$1K Sell
6
-72
-92% -$12K ﹤0.01% 3351
2017
Q1 		$20K Buy
78
+7
+10% +$3.75K ﹤0.01% 3071
2016
Q4 		$69K Buy
71
+32
+82% +$28.7K ﹤0.01% 2766
2016
Q3 		$33K Hold
39
– – ﹤0.01% 2700
2016
Q2 		$28K Buy
+39
New +$26.7K ﹤0.01% 2766

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Legal & General Group's ALT Position: Q1 2026 in Review

Legal & General Group increased its Altimmune (ALT) stake by 23% in Q1 2026, buying an estimated $9.06K and bringing the position to 11,496 shares worth $35.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2770.

Legal & General Group first reported a position in ALT in Q2 2016 and has held it in 24 quarters since. The position peaked at $684K in Q3 2022. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • Legal & General Group held 11,496 shares of Altimmune worth $35.4K as of Q1 2026.
  • Legal & General Group bought 2,134 Altimmune shares in Q1 2026, an estimated $9.06K.
  • Altimmune made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #2770 holding.
  • Legal & General Group first reported a position in Altimmune in Q2 2016 and has held it in 24 quarters since.
  • Legal & General Group's Altimmune position peaked at $684K in Q3 2022.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.